stavudine has been researched along with Nerve Pain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bilbrey, JA; Felix, JS; McCurdy, CR; McMahon, LR; Wilkerson, JL | 1 |
| Estiasari, R; Imran, D; Octaviana, F; Price, P; Ranakusuma, T; Safri, AY; Setiawan, DD | 1 |
| Bathgate, G; Bennett, DLH; Calvo, M; Huang, W; Karu, K; Okuse, K; Olausen, HR; Rice, ASC | 1 |
| Galeotti, N; Ghelardini, C; Sanna, MD | 1 |
| Bansal, Y; Kuhad, A; Marwaha, L; Saroj, P; Singh, R; Sodhi, RK | 1 |
| Backonja, MM; Baron, R; Bennett, MI; Bouhassira, D; Cruccu, G; Haanpää, ML; Hansson, PT; Jensen, TS; Kauppila, T; Rice, AS; Smith, BH; Treede, RD | 1 |
1 review(s) available for stavudine and Nerve Pain
| Article | Year |
|---|---|
Assessment of neuropathic pain in primary care.
Topics: Adult; Anti-HIV Agents; Diagnosis, Differential; Evoked Potentials, Somatosensory; Female; Humans; Lymph Node Excision; Mastectomy; Medical History Taking; Middle Aged; Neuralgia; Pain; Pain Measurement; Physical Examination; Primary Health Care; Reverse Transcriptase Inhibitors; Severity of Illness Index; Stavudine; Thermosensing; Touch; Vibration | 2009 |
5 other study(ies) available for stavudine and Nerve Pain
| Article | Year |
|---|---|
Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine.
Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Neuralgia; Stavudine | 2021 |
Neuropathic pain in HIV patients receiving ART without stavudine in an Indonesia Referral Hospital.
Topics: Adult; Anti-Retroviral Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Indonesia; Male; Neuralgia; Prevalence; Risk Factors; Stavudine | 2019 |
A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy.
Topics: Activating Transcription Factor 3; Animals; Anti-HIV Agents; Brain; Calcitonin Gene-Related Peptide; Disease Models, Animal; Exploratory Behavior; Ganglia, Spinal; Gene Expression Regulation, Viral; HIV Infections; Hyperalgesia; Lectins; Male; Nerve Tissue Proteins; Neuralgia; Neuropeptide Y; Psychomotor Performance; Rats; Rats, Wistar; Reproducibility of Results; Sensory Receptor Cells; Stavudine; Sural Nerve; Time Factors | 2013 |
Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
Topics: Animals; Anthracenes; Anti-Retroviral Agents; Brain-Derived Neurotrophic Factor; Caspase 3; Cold Temperature; Hyperalgesia; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Models, Animal; Neuralgia; Protein Kinase Inhibitors; Random Allocation; Spinal Cord; Stavudine; Touch; Zalcitabine | 2016 |
Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.
Topics: Analgesics; Animals; Biomarkers; Dose-Response Relationship, Drug; Hyperalgesia; Interleukin-1beta; Lipid Peroxidation; Male; Motor Activity; Neural Conduction; Neuralgia; Niflumic Acid; Nitrites; Oxidative Stress; Rats, Sprague-Dawley; Stavudine; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2016 |